ANAB
AnaptysBio IncNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$1.74B
P/E Ratio
—
EPS
$-1.02
Beta
0.48
52W High
$72.36
52W Low
$11.40
50-Day MA
$52.44
200-Day MA
$32.35
Dividend Yield
—
Profit Margin
-11.50%
Forward P/E
—
PEG Ratio
0.00
About AnaptysBio Inc
AnaptysBio, Inc., a clinical-stage biotechnology company, is dedicated to developing therapeutic product candidates for inflammation and immuno-oncology indications. The company is headquartered in San Diego, California.
Fundamentals
| Revenue (TTM) | $232.39M |
| Gross Profit (TTM) | $103.61M |
| EBITDA | $41.34M |
| Operating Margin | -135.50% |
| Return on Equity | -114.50% |
| Return on Assets | 6.78% |
| Revenue/Share (TTM) | $8.22 |
| Book Value | $0.44 |
| Price-to-Book | 136.16 |
| Price-to-Sales (TTM) | 7.48 |
| EV/Revenue | 6.29 |
| EV/EBITDA | 25.01 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | -8.00% |
| Shares Outstanding | $29.10M |
| Float | $19.55M |
| % Insiders | 5.74% |
| % Institutions | 96.92% |
Historical Volatility
HV 10-Day
45.80%
HV 20-Day
68.56%
HV 30-Day
79.94%
HV 60-Day
77.51%
HV Rank
82.9%
Volatility is currently contracting
Analyst Ratings
Consensus ($84.45 target)
3
Strong Buy7
Buy1
HoldMore HEALTHCARE Stocks
Data last updated: 5/25/2026